Top 50 Startup Investors in Switzerland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Zürcher Kantonal Bank
VC Fund
|
145 | Switzerland, Germany, Japan | Seed, Series A | Health Care, Medical Device, Biotechnology | $1.2M–$14M |
|
Foundation for Innovation and Technology (FIT)
VC Fund
|
128 | Switzerland, France, United States | Debt Financing, Grant, Seed | Health Care, Biotechnology, Information Technology | $23k–$1.2M |
|
Verve Ventures
VC Fund
|
115 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $1.4M–$43M |
|
SICTIC
VC Fund
|
111 | Switzerland, Germany, United Kingdom | Seed, Pre-Seed | Software, Artificial Intelligence, Information Technology | $233k–$2.9M |
|
Founderful
VC Fund
|
84 | Switzerland, United Kingdom, Canada | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $1.1M–$24M |
|
VI Partners
VC Fund
|
41 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
Serpentine Ventures
VC Fund
|
38 | Switzerland, Germany, United States | Seed, Pre-Seed | Software, Information Technology, Automotive | $650k–$7M |
|
3wVentures
VC Fund
|
36 | Switzerland, Spain, Austria | Seed, Angel, Series A | Software, Health Care, Medical | $50k–$8M |
|
Swisscom Ventures
VC Fund
|
36 | Switzerland, United States, United Kingdom | Series B, Series A | Software, SaaS, Information Technology | $1.8M–$59M |
|
redalpine
VC Fund
|
35 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.6M–$59M |
|
GoBeyond
VC Fund
|
34 | Switzerland, Germany, United Kingdom | Seed, Series A | Information Technology, Medical, Software | $544k–$10M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
34 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$40M |
|
Kickfund
VC Fund
|
33 | Switzerland, Germany | Seed, Pre-Seed, Convertible Note | Manufacturing, Medical, Health Care | $109k–$6M |
|
Alpana Ventures
VC Fund
|
33 | United States, Switzerland, Germany | Seed, Series A | Software, FinTech, Information Technology | $850k–$14M |
|
BackBone Ventures
VC Fund
|
32 | Switzerland, Germany, Israel | Pre-Seed, Seed, Series A | Artificial Intelligence, Information Technology, Software | $583k–$105M |
|
Spicehaus Partners
VC Fund
|
32 | Switzerland | Seed, Series A | Information Technology, Software, Machine Learning | $874k–$10M |
|
b2venture
VC Fund
|
28 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
Polytech Ventures
VC Fund
|
28 | Switzerland, United States, Spain | Seed, Series A | Financial Services, FinTech, Software | $1M–$9.7M |
|
Founderful Campus
VC Fund
|
24 | Switzerland, Bulgaria, United States | Pre-Seed, Convertible Note, Seed | Information Technology, Artificial Intelligence, Robotics | $21k–$2.9M |
|
EquityPitcher Ventures
VC Fund
|
22 | Switzerland, Germany, Canada | Series A, Seed | Software, Information Technology, SaaS | $1.7M–$11M |
|
ACE & Company
VC Fund
|
22 | United States, Switzerland, United Kingdom | Seed, Series A | Software, Financial Services, FinTech | $1M–$24M |
|
BioMedPartners
VC Fund
|
20 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.9M–$83M |
|
Session.vc
VC Fund
|
19 | Switzerland, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1M–$18M |
|
StartAngels Network
VC Fund
|
17 | Switzerland, Brazil | Seed, Series A, Series B | Medical, Health Care, Medical Device | $933k–$6.1M |
|
TiVentures
VC Fund
|
17 | Switzerland, Italy, United States | Seed, Series A | Software, Analytics, SaaS | $583k–$3.3M |
|
Technology Fund
VC Fund
|
17 | Switzerland, Italy, Germany | Debt Financing, Grant, Seed | Software, Energy, Information Technology | $1.2M–$8.3M |
|
SIX FinTech Ventures
VC Fund
|
16 | Switzerland, United Kingdom, Spain | Seed, Series A, Series B | Financial Services, FinTech, Finance | $1.6M–$80M |
|
Innosuisse
VC Fund
|
15 | Switzerland, United States, United Kingdom | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Medical Device | $17k–$16M |
|
M Ventures
VC Fund
|
15 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
ETH Zurich Foundation
VC Fund
|
14 | Switzerland | Seed, Grant, Pre-Seed | Information Technology, Medical, Software | $162k–$5.8M |
|
DAA Capital Partners
VC Fund
|
13 | Switzerland, France | Seed, Series A | Software, Information Technology, Artificial Intelligence | $816k–$7.5M |
|
FortyOne Group
VC Fund
|
13 | Switzerland, Germany | Seed, Series A | Information Services, Information Technology, Software | $699k–$9.6M |
|
Novartis Venture Fund
VC Fund
|
13 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
Acequia Capital (AceCap)
VC Fund
|
13 | United States, United Kingdom, Switzerland | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $620k–$25M |
|
Gentian Investments
VC Fund
|
13 | Switzerland, Germany, United States | Seed, Series A | Software, Artificial Intelligence, Machine Learning | $933k–$13M |
|
FYRFLY Venture Partners
VC Fund
|
13 | United States, Switzerland, France | Seed, Series A | Software, SaaS, Artificial Intelligence | $1.3M–$14M |
|
Kinled Holding
VC Fund
|
12 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $648k–$40M |
|
QBIT Capital
VC Fund
|
12 | Switzerland | Seed, Pre-Seed, Series A | Software, Internet, Analytics | $1M–$5.4M |
|
Eclosion SA
VC Fund
|
12 | Switzerland | Seed, Series C | Biotechnology, Pharmaceutical, Health Care | $1.6M–$28M |
|
Myke Naf
Angel
|
12 | Switzerland, Germany | Seed, Angel, Pre-Seed | Software, E-Commerce, Food and Beverage | $340k–$1.9M |
|
EQT Life Sciences
VC Fund
|
12 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$165M |
|
Penny Schiffer
Angel
|
12 | Switzerland, Germany, United Kingdom | Seed, Series A | Medical, Health Care, Finance | $544k–$9.3M |
|
Sofinnova Partners
VC Fund
|
12 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
S2S Ventures
VC Fund
|
12 | Switzerland, Germany | Pre-Seed, Seed | Health Care, Manufacturing, Artificial Intelligence | $29k–$4.5M |
|
TR Invest
VC Fund
|
12 | Switzerland, Spain, Sweden | Seed, Series A | Manufacturing, Software, Apps | $350k–$3.5M |
|
Privilège Ventures
VC Fund
|
12 | Switzerland, France | Seed, Series A | Health Care, Hardware, Software | $1.2M–$7M |
|
Momenta
VC Fund
|
11 | United States, Switzerland, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Internet of Things | $1M–$60M |
|
4FO Ventures
VC Fund
|
11 | Switzerland | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.1M–$54M |
|
TX Ventures
VC Fund
|
11 | Switzerland, Germany, United Kingdom | Seed, Series A, Series B | Financial Services, FinTech, Finance | $1.3M–$34M |
|
SOSV
VC Fund
|
11 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
| Access all 3603 investors in Switzerland startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Switzerland, Germany, Japan
Investor stats
- Total investments: 187
- Round size: Seed $1.2M–$6M; Series A $2.3M–$14M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- TestResults — TestResults uses the TrueTest technology and AI-based virtual user that makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. The company has simplified automated testing massively and reduced time radically. With it, the automation andmaintenance effort is reduced to a minimum that allows zero flakiness and the enlightening feeling of being in control of automation and test scenarios.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
- Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France, United States
Investor stats
- Total investments: 167
- Round size: Seed $117k–$1.2M; Grant $23k–$125k; Debt Financing $100k–$583k
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Phonemia — Phonemia is a digital health company that offers artificial intelligence and speech therapy services.
- MoleSense — Developing continuous molecular monitoring wearables to enable proactive healthcare.
- DiverSsiTy SA — DiverSsiTy SA develops personalized, patient-centric digital health technologies (DHTs) to improve the lives of patients suffering from neurodevelopmental disorders (NDDs), among which are those with autism spectrum disorder (ASD) and related comorbidities like attention-deficit/hyperactivity disorder (ADHD).
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 260
- Round size: Seed $1.4M–$10M; Series A $2.3M–$17M; Series B $4.2M–$43M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $66M in 2022
Portfolio highlights
- Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
- Biograil — Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery ofthe biologic efficiently into the gastrointestinal wall.
- iMusician — iMusician offers music distribution, promotion, mastering, and monetization for independent musicians & labels. Get on Spotify, Apple Music, Amazon, TikTok & many more.
SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 128
- Round size: Seed $583k–$2.9M; Pre-Seed $233k–$2.1M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Qala — Qala delivers real-time data classification, discovery, and policy enforcement. Auto-classify sensitive data, map full lifecycles, and label at source.
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- Ionic Wind Technologies — Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
Founderful operates as a venture capital firm and a Switzerland’s leading pre-seed fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, United Kingdom, Canada
Investor stats
- Total investments: 96
- Round size: Seed $1.5M–$16M; Pre-Seed $1.1M–$3.8M; Series A $3.4M–$24M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $85M in 2024
Portfolio highlights
- EthonAI — Ethon is the #1 Industrial AI platform, built to turn production data into business value. It empowers engineers and operators with agentic workflows to understand, improve, and control their production processes.
- AVIAN —
- Flink — Drop-in robots for logistics operations. Handle any object, anywhere, autonomously. Enabled by our physical intelligence layer.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 110
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Altoida — Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
- SMART VALOR — SMART VALOR is a secure investment platform offering easy buy and sell of cryptocurrencies like Bitcoin, Ethereum, Dash and more. Trade and store digital assets.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Serpentine Ventures (SERV) is the investment arm of the Swiss startup group. Serpentine refers to the meandering roads found across the Swiss Mountains. Unreachable mountain peaks become accessible by following the serpentine path.
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 79
- Round size: Seed $1.2M–$7M; Pre-Seed $650k–$1.7M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Apaleo — Transform your hospitality business with an open platform. Easily connect 3rd party applications to build a best-in-class tech stack for your hotel
- Evulpo — Creating Futures - For students from Year 3 to Year 13. Exactly according to the national curriculum. Learn always and everywhere with evulpo.
- Isochronic — Isochronic manufactures industrial robotic products for pick and place applications by transporting multiple parts simultaneously.
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: Switzerland, Spain, Austria
Investor stats
- Total investments: 42
- Round size: Seed $50k–$3.8M; Angel $583k–$2.1M; Series A $1.2M–$8M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — raised $100M in 1999
Portfolio highlights
- Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
- GUURU Solutions — Discover how community-powered advice can turn your PDPs into trusted, high-converting content and get cited in AI search.
- Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series B, Series A
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 142
- Round size: Series A $1.8M–$23M; Series B $2.3M–$59M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Bring! Labs — Bring! Labs is an app for multi-device use that accompanies the user through all aspects of shopping for groceries and other everyday items. It offers grocery shopping for millions of people with shared shopping lists, integrated recipes, online shopping, local offers, and loyalty cards. Bring! Labs offers innovative mobile advertising platforms tocompanies in the retail and FMCG.
- Kandou AI — We enable faster and more energy efficient interconnects with a smaller physical footprint than competing technologies. Our chip connection technologies improves the speed to power consumption trade-off frontier.
- amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 181
- Round size: Seed $1.6M–$12M; Series A $3.2M–$31M; Series B $15M–$59M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $25M in 2013
Portfolio highlights
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
- Albatross AI — Inspire Customers Boost Conversions Capture Missed Revenues
- Hypervision Surgical — Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more...Investment focus
- Industry: Information Technology, Medical, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 163
- Round size: Seed $544k–$5M; Series A $1.2M–$10M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Fastree3D — Fastree3D imaging sensors help recognize and measure distance to fast moving objects in real-time, enabling driving assistance or autonomous navigation. Fastree3D SA is a fabless semiconductor company, spin-off from EPFL Lausanne, Switzerland founded in September 2013 (UID CHE-291.330.490). The company subsidiary Fastree3D B.V. performs researchwith TU-Delft, Netherlands (KvK 58866973).
- Spyra One — Single Shot Technology | Tactical display | Automatic Refill | Power Shot SpyraTwo - the world's strongest water gun! Start epic water battles with the only water gun in the world that features our patented Single-Shot-Technology, fully automatical pump, a hightech tactical display and the Power Shot for extra impact.
- Arktis Radiation Detectors — Arktis develops and manufactures next generation systems that detect and categorize radiological and nuclear materials to enhance security and operations.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 555
- Round size: Seed $909k–$7.4M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- TRAIT — TRAIT Running Coach app for your iphone or ipad tablet.
- Certivity — Certivity offers software to model digital regulatory twins of their products. This will ensure that current regulatory requirements are integrated in the right place in the engineering process. Product compliance will be smarter, safer, more transparent, more efficient, and significantly cheaper.
- Scavenger AI — Scavenger AI helps businesses transform complex data into clear, actionable insights.
Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Switzerland, Germany
Investor stats
- Total investments: 37
- Round size: Seed $1.7M–$6M; Pre-Seed $335k–$4.4M; Convertible Note $109k–$121k
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Rhovica Neuroimaging — Rhovica Neuroimaging is a rapid and safe placement of an external ventricular drain (EVD) and is a lifesaving emergency procedure. EVDs are thin catheters, that are inserted into the brain cavities (ventricles) for fluid drainage to decrease intracranial pressure (ICP) and for measurement of ICP.
- Cosaic — Cultivated - Creamy, dairy-free indulgence
- Ionic Wind Technologies — Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Seed, Series A
- Geography: United States, Switzerland, Germany
Investor stats
- Total investments: 97
- Round size: Seed $850k–$4M; Series A $2.3M–$14M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
- Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
- Tinamu — Trusted inventory intelligence delivered in real-time
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 69
- Round size: Seed $966k–$5M; Pre-Seed $583k–$2.1M; Series A $5M–$105M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
- Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
- Voliro — The multi-purpose robotic flight platform redefining work at height. NDT Solutions for elevated insights about your critical infrastructure.
Venture Capital made in Switzerland Who we are Strong Investment Portfolio more than 40 companies funded Our portfolio Driving digital transformation By backing successful founders Our approach 01 We drive digital transformation in Switzerland Spicehaus Partners AG is an independent Swiss venture capital investor, fully owned by its partners. We focus on early-stage companies in
Show more...Investment focus
- Industry: Information Technology, Software, Machine Learning
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 44
- Round size: Seed $874k–$2.7M; Series A $3.5M–$10M
- Lead/follow: 73% lead, 27% follow
- Last fund: May invest from a new fund soon — raised $54M in 2019
Portfolio highlights
- xorlab — xorlab offers machine-intelligent email security that stops advanced phishing, business email compromise, and other emerging threats at first sight.
- Vlot — Vlot is offering intergrated life risk analysis, life insurance coverage and dynamic life planning solutions combined with digital underwriting through cutting edge APIs and algorthims.
- amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 230
- Round size: Seed $1.3M–$9M; Series A $4M–$22M; Series B $8M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
- Ververica — Ververica is the company founded by the original creators of Apache Flink, enabling companies to run in real-time with Ververica Platform.
- Seven Senders — Excellent international delivery is a competitive advantage. Connect with Seven Senders and benefit. Find out more now!
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: Switzerland, United States, Spain
Investor stats
- Total investments: 50
- Round size: Seed $1M–$5M; Series A $2.3M–$9.7M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
- Hemostod — Developing universal platelets and next-generation diagnostics
- Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Founderful Campus aims to educate students and support entrepreneurs to disrupt the startup culture on campuses, producing the next generation of tech leaders, and creating more value for society.
Show more...Investment focus
- Industry: Information Technology, Artificial Intelligence, Robotics
- Stage:Pre-Seed, Convertible Note, Seed
- Geography: Switzerland, Bulgaria, United States
Investor stats
- Total investments: 28
- Round size: Seed $2.3M–$2.9M; Pre-Seed $23k–$2.9M; Convertible Note $21k–$31k
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
- Impact.build — Impact Build transforms excavated earth into low-carbon building elements using advanced robotic manufacturing, delivering circular construction that competes on both cost and performance.
- Aurora Analytics — Track and optimize your brand visibility across AI search engines. The leading GEO tracking and AI search optimization platform.
As active investors, Equity Pitcher carry out a needs and network analysis as part of the due diligence process and thus evaluate the added value we can offer the founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed
- Geography: Switzerland, Germany, Canada
Investor stats
- Total investments: 49
- Round size: Seed $1.7M–$5.5M; Series A $3.4M–$11M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- abaut — Abaut GmbH delivers AI-powered process intelligence for quarries, mining sites, and construction operations. SiteView OS gives real-time visibility into quarry process monitoring, mass flow, mixed fleets, and Load-Haul-Dump cycles. With smart analytics, teams work faster, reduce delays, and replace manual analysis with clear, data-driven decisions.
- Enzo — Enzo is a Heidelberg based InsurTech startup offering modern and smart insurance coverage for homeowners. Instead of just reacting to claims, Enzo takes a proactive customer-focused approach to prevent damages from happening at all. Thus, Enzo is leading a paradigm shift in a €100+ billion market that has barely improved customer experience forover 100 years. Our Goal is to become Europe's smartest homeowners insurance.
- eternal.ag — eternal.ag develops robotics and AI solutions for greenhouse farming. It builds autonomous robots, like its flagship Harvester for tomatoes, to address labor shortages and enable year-round fresh produce production.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ACE offers three core investment strategies across the stages of private investment: Secondaries, Buyout, and Venture. Our portfolio construction guidelines ensure that our investors access the necessary customization to achieve their risk and return requirements.ACE aims to drive returns by managing risks and strategically adjusting investmentexposure to the stage of a company’s development. We strongly believe that diversification and sizing of investments according to the risk profile are the most effective approaches to investing private capital.ACE’s specialized investment teams provide the support to create long-term and sustainable investment results.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 184
- Round size: Seed $1M–$6.4M; Series A $3.4M–$24M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Roofr — The complete sales toolbox for roofers. From roof measurement reports to project-winning proposals.
- Vennre — Build wealth through vetted private market opportunities from $5k. GCC-first, globally accessible. Regulated, Sharia-compliant, digital-first.
- PatientPoint — Discover how PatientPoint delivers content that drives better health decisions and outcomes for healthcare providers, brands, and patients.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 87
- Round size: Series A $5.3M–$26M; Series B $4.9M–$83M; Series C $5.8M–$48M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $113M in 2018
Portfolio highlights
- Vaximm — Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinicaltrials in 2011.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
At session we back early-stage companies in the Software and Consumer space. As active investors, we can only partner with a few companies. When we do, we roll up our sleeves and get to work, providing entrepreneurs with access to expertise and insights across the entire spectrum of company building.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 22
- Round size: Seed $1.3M–$16M; Pre-Seed $1M–$2.9M; Series A $3.6M–$18M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Saporo — Improve cyber resistance by prioritizing and reducing user access risk.
- Cerrion — Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop.
- deskbird — Most intuitive and people-centric - deskbird's hybrid workplace solution that employees will love. For all flexibe companies, from startup to corporate.
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Brazil
Investor stats
- Total investments: 26
- Round size: Seed $933k–$3.7M; Series A $2.1M–$3.7M; Series B $1.7M–$6.1M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Calingo — Calingo is a digital insurance platform that offers personalised and optimised risk protection at the point of sale.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
- Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more...Investment focus
- Industry: Software, Analytics, SaaS
- Stage:Seed, Series A
- Geography: Switzerland, Italy, United States
Investor stats
- Total investments: 23
- Round size: Seed $583k–$2.2M; Series A $1.9M–$3.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- InkVivo — InkVivo provides clinicians and healthcare providers with a product delivery system that optimizes treatments. Their manufacturing approach allows users to design implantable patches, tablets, and injectable biomaterials.
- Artificialy — Artificialy provides custom AI solutions, consulting, and training for enterprises in Switzerland and beyond. Artificial Intelligence actually delivered.
- Jaipur Robotics — Jaipur Robotics focuses on developing AI software for waste recycling ecosystem.
Technology Fund offers loan guarantees to Swiss companies whose novel products contribute to a sustainable reduction in greenhouse gas emissions
Show more...Investment focus
- Industry: Software, Energy, Information Technology
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, Italy, Germany
Investor stats
- Total investments: 52
- Round size: Seed $1.2M–$8.3M; Debt Financing $1.7M–$3.5M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Distran — Distran ultrasonic cameras detect leaks of any type of gas in industrial facilities at a distance with live leak rate quantification. ATEX-certified.
- Bionomous — Automating tomorrow's biology. Our technology handles all small biological entities from 0.5 to 2mm. From fish eggs to 3D models, like organoids and spheroids
- AgroSustain — AgroSustain is a one-stop-shop solution for biological plant protection. It aims to reduce food waste and support organic food production by developing farm to fork solutions, like biological fungicides and coatings.
SIX invests in global early stage start-ups, focusing on companies that provide value to the Swiss financial center.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Seed, Series A, Series B
- Geography: Switzerland, United Kingdom, Spain
Investor stats
- Total investments: 35
- Round size: Seed $1.6M–$8.5M; Series A $4.1M–$24M; Series B $25M–$80M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Anapaya — The SCION Internet architecture developed at ETH Zurich is a disruptive technology that provides secure inter-domain routing, QoS, DDoS defense mechanisms, resilient public-key infrastructures, and an unprecedented level of availability. We leverage the SCION architecture to offer next-generation Internet services and address the flaws andlimitations of today’s Internet.
- Doconomy — Doconomy is a Sweden-based fintech company that offers digital banking services. Their vision is of enabling a sustainable lifestyle for everyone. Doconomy wants to inspire change in behaviour and reduce unsustainable consumption and carbon emissions. Doconomy activates a circular ecosystem, connecting the consumer, the producer, the retailer andinfluencer to futureproof planet earth, and achieve a sustainable lifestyle for all.
- PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Pre-Seed, Seed
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 222
- Round size: Seed $500k–$16M; Grant $51k–$2.9M; Pre-Seed $17k–$4.3M
- Lead/follow: 81% lead, 19% follow
Portfolio highlights
- Sparkli — Sparkli offers an AI-powered educational platform that turns children’s questions into interactive learning journeys called “expeditions.” The platform generates multimodal content blending visuals, audio narration, games, and quizzes to help learners explore topics and build skills like design thinking, financial literacy, sustainability, andemotional intelligence. It personalizes experiences using generative AI so that young learners engage with content aligned to their curiosity and interests. Sparkli also includes features to track progress and encourage regular engagement through challenges, rewards, and creative reflections. The platform supports both individual exploration and guided learning contexts for children.
- OrthoSens — OrthoSens develops battery-free sensors that turn standard orthopedic implants into smart, data-driven devices. Unlike existing smart implant solutions that require an implanted battery making them too large and too risky to scale beyond large joints, OrthoSens moves all electronics outside the body. A paper-thin sensor integrates directly intoexisting implants with no battery, no surgical workflow change and zero explant risk. An external wearable powers the sensor wirelessly and collects real-time data on load, micromotion and bone fusion. The result is a footprint 250x smaller than battery-powered competitors, opening up additional spine, foot & ankle markets that existing solutions cannot address. The clinical need is clear: approximately 20% of post-surgical patients drive around 68% of total post-operative costs through missed complications, continuous implant monitoring exists to catch them earlier. Starting January 2026, 745 US hospitals enrolled in CMS's mandatory TEAM bundle are now accountable for 30-day episode costs, creating direct institutional demand for this data.OrthoSens generates revenue through three streams: sensor sales to orthopedic implant manufacturers (unlocking +$1,309 NTAP reimbursement per unit), a SaaS subscription capturing 40% of Medicare's $104/month RPM reimbursement per patient and post-market data analytics. The company has validated its technology across 3 functional prototypes, filed 2 core patents with favorable Freedom to Operate and secured $1.3M+ in non-dilutive funding. It is raising a $2.3M seed round to complete ISO-13485 certification, conduct the FDA pre-clinical study and file a 510(k) submission. The team is led by Gwenael Hannema (3x medtech founder), Dr. Oleg Kotsur (Head of R&D), and key employees, supported by experienced board members with leadership backgrounds at Novartis, Medtronic and J&J MedTech.
- Reverso Therapeutics — Reverso medicines is a biotechnology company that offers therapeutic medicines for anticoagulant therapy.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 170
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
ETH Zurich Foundation is an independent, non-profit-making foundation under private law for the promotion of education and research at ETH Zurich.
Show more...Investment focus
- Industry: Information Technology, Medical, Software
- Stage:Seed, Grant, Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 21
- Round size: Seed $1.2M–$5.8M; Grant $162k–$175k; Pre-Seed $490k–$4.4M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- FenX — FenX is a recyclable insulating product that turns mineral waste into usable resources to support a circular economy. Real estate developers, construction companies, and architects can now access non-flammable insulation materials for construction processes. the company's portfolio of recyclable insulation materials, which includes foamproducts and foam formulations made from readily available waste or natural materials with CO2 emissions.
- Soverli —
- Tethys Robotics — Tethys Robotics develops AI-powered application oriented robotics system that enables professionals in carrying underwater search & recovery to inspection & surveillance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!DAA Capital Partners is a Swiss-based private equity generating significant returns on technology-driven companies and real estate opportunities
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Switzerland, France
Investor stats
- Total investments: 16
- Round size: Seed $816k–$2.3M; Series A $4.1M–$7.5M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Largo.ai — We make the data-driven movie-making accessible to the market through our high level film understanding technologies. Largo has developed data-driven intelligence, which can be introduced much earlier in the life of a film project, right from script choice and development, through filming, post-production and theatrical release. Largo empowersproduction companies with data-enhanced ROI uplift and reduction of risk.
- Touch Sensity — Touch Sensity is an information technology company that specializes in the fields of IoT and sensors.
- Cognitive Design Systems — Cognitive Design Systems (CDS) is a software company enabling designers and engineers to automate and accelerate their design process using AI. Our software converts concept designs into manufacturable, sustainable and economically viable products using machine learning algorithms.
At Fortyone AG they hold participations in non-listed companies. They are guided by the question: "Can they make a difference?". As active investors, they make investments in which, in addition to the financial resources, they can add value to their knowledge, their experience and their relationships. In order to live up to this smartmoney approach and to be able to actively influence the corporate design, they usually require the involvement of the Board of Directors. The scope of the participation depends on the requirements.
Show more...Investment focus
- Industry: Information Services, Information Technology, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany
Investor stats
- Total investments: 18
- Round size: Seed $699k–$9.6M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Meteomatics — Meteomatics is a company that specializes in the specific IT needs of the weather, energy and trading industries. With more than 10 years of experience in the development of market leading forecasting systems and the rapid processing of weather data, they are happy to assist you with tailor-made solutions.
- Catchfree — Catchfree uses a proprietary process to produce seafood substitutes that are appealing to consumers due to their excellent flavor, texture, appearance, and nutritious content.
- memox. — Memox Innovations provides workshops, scheduling, and meeting spaces. Memox Innovations was founded in 2016 and is based in Zürich, Zürich.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 213
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 229
- Round size: Seed $1.2M–$8M; Pre-Seed $620k–$3.3M; Series A $5M–$25M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $4M in 2019
Portfolio highlights
- Kindred — Kindred Labs is building the default interface for human–AI interaction — always-on, trusted companions that unify productivity, commerce, and emotional connection into a single relationship. As the only AI company officially trusted by 25+ iconic IPs, including Sanrio, Warner Bros., LINE Friends, and Pudgy Penguins, Kindred Labs sits on a uniquecultural and distribution moat powered by billions of existing fans worldwide.Kindred’s growth has been consistently explosive: the company has attracted millions of registered users within weeks of opening access, climbed into the Top 10 on DappRadar with hundreds of thousands of on-chain daily and monthly active users and millions of on-chain transactions in a single month, and driven an NFT free-mint that organically reached above a 1.3 ETH floor, alongside outsized gains in brand mindshare and category visibility (including a #1 gainer ranking on Kaito).Backers and partners include SEI Foundation, Protocol Labs, 0G Foundation, Techstars, Orange DAO, Sky Mavis, CoinMarketCap Labs, Nvidia Inception, ElevenLabs, and others. Kindred Labs is founded by Max Giammario, whose M.A./Ph.D.-level research focuses on human–AI interaction, and is built by a team of experts from companies such as Apple and Disney.
- Doppler Labs — 2026's Top 5 Best Headphones Top Rated and Reviewed. Easily choose and compare the Best Headphones for you all in one place. (Fan Favorites)
- Flow Engineering — Requirements management, made collaborative
Gentian is an early-stage investment company founded by the Entrepreneurs Elian Kool and Gerhard Gerner. We focus on investments in SaaS platforms, Mobile, Robotics/Drones and adjacent areas we have a passion for.Based in Switzerland, most of our investments are in the DACH region, but with a clear focus on a global market.We investexclusively in enthusiastic teams, which we support with our experience as entrepreneurs as board member or advisor.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 17
- Round size: Seed $933k–$10M; Series A $2.1M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Creaitor — Creaitor is the ultimate solution for content producers, offering a comprehensive suite of AI tools and integrated SEO features. Streamline your content creation process and optimize your online presence with our powerful platform.
- Yeastup — Yeastup transforms brewer's yeast into proteins & fibers for food & supplements. Contact us for sustainable ingredient solutions.
- Sunflower Labs — Fully autonomous AI-powered drone security with thermal imaging and real-time threat detection for commercial, industrial, and residential properties.
Fyrfly Venture Partners is a venture capital firm that focuses on data and intelligence. The firm prefers to invest in startups and early-stage companies in the information technology sector.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Switzerland, France
Investor stats
- Total investments: 42
- Round size: Seed $1.3M–$9M; Series A $3.4M–$14M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $2M in 2022
Portfolio highlights
- Locatee — Locatee is the leading workplace analytics solution that transforms complex data into space utilisation insight. Developed with a strong focus and a deep understanding of the corporate real estate challenges facing the modern world of work, Locatee empowers leaders and managers to make decisions about their business buildings with confidence.Locatee works by leveraging office occupancy data from multiple sources, processing them using unique patented technology, and beautifully visualising them all in one place. With workplace intelligence at fingertips’ length, it’s easy to identify optimisation potential, realise savings, and enhance company’s workplace experience across the entire real estate portfolio.
- Beekeeper — Beekeeper is the employee app built for frontline success. Connect frontline teams, boost engagement, and make every shift more productive.
- Capsule Social — Reconnect with your past experiences through your personal social memory app
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 117
- Round size: Seed $648k–$11M; Series A $2M–$40M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
We are QBIT Capital, an early stage venture capital firm focused on founders in Switzerland.
Show more...Investment focus
- Industry: Software, Internet, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 14
- Round size: Seed $1M–$5.4M; Pre-Seed $1M–$3M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- DuraMon — DuraMon provides sensor for monitoring durability in concrete.
- DPhi Space — DPhi Space is a startup that specializes in shared satellites for hosted payloads to simplify access to space. The company's flagship product, Clustergate, is a modular platform that aggregates multiple payloads—such as sensors, antennas, or cameras—into a single container, allowing them to share a satellite. This approach reduces costs andcomplexity by optimizing satellite resources. Clustergate offers built-in in-orbit computing, AI processing, and real-time data analytics, enabling businesses to deploy and manage their technology in space without requiring specialized expertise.
- LogBook — LogBook creates AI and machine learning platforms for logistics location profiling. The company's platform provides up-to-date information on facility coordinates, operation hours, and location data sharing with stakeholders, as well as large-scale public transit node data, allowing clients to manage, access, and share logistics locationinformation.
Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series C
- Geography: Switzerland
Investor stats
- Total investments: 16
- Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
- Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
- MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Myke Naf is the Managing Partner of Übermorgen Ventures.He attended University of St.Gallen.
Show more...Investment focus
- Industry: Software, E-Commerce, Food and Beverage
- Stage:Seed, Angel, Pre-Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 16
- Round size: Seed $396k–$1.9M; Pre-Seed $340k–$1.9M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Yokoy — Yokoy automates spend management for medium and large enterprises with artificial intelligence, combining expense management, supplier invoice management, and smart corporate cards into one single intuitive platform. In March 2019, Yokoy Group AG was created as Expense Robot GmbH.
- Delicious Data — Delicious Data offer a demand forecast engine to solve the problem of planning uncertainty in the food service and catering industry. Delicious Data machine learning solution enables kitchen chefs to optimize purchase and production planning saving valuable resources and reducing costs.
- Frontify — Frontify is a brand-building platform where a user-friendly digital asset management system meets customized brand portals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 174
- Round size: Series A $6.9M–$77M; Series B $12M–$103M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.
- Simplify Medical — Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine. It offers an MRI compatible motion preserving artificial cervical disc that is used to treat single level symptomatic cervical disc disease.The company provides its products for skeletally mature patients for reconstruction of the disc at onelevel from C3-C7 following single-level discectomy for intractable radiculopathy, such as arm pain or a neurological deficit.Simplify Medical was founded in 2015 and is based in Mountain View, California.
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Medical, Health Care, Finance
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $544k–$9.3M; Series A $1.2M–$7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Artificial Intelligence
- Stage:Pre-Seed, Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 15
- Round size: Seed $2.9M–$3.4M; Pre-Seed $29k–$4.5M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $13M in 2021
Portfolio highlights
- Haicker — Haicker is an AI-driven cybersecurity platform designed to automatically detect vulnerabilities in web application codebases with exceptional precision. Leveraging advanced Large Language Model (LLM)-based agents, Haicker outperforms traditional security testing solutions by removing false positives and providing actionable insights that helpdevelopers fix vulnerabilities swiftly and confidently.Traditional static (SAST) and dynamic (DAST) application security testing tools typically suffer from high rates of false positives, demanding significant manual review efforts from developers and security teams. Haicker addresses this core challenge through its unique architecture: all issues are validated against a replica of the application, allowing Haicker to filter real findings from hallucinations.Initially proven in competitive cybersecurity environments like Capture-the-Flag (CTF) competitions, Haicker quickly demonstrated superior performance and reliability on open source projects. Its capabilities extend beyond vulnerability scanning, integrating seamlessly into common development workflows, including continuous integration and delivery pipelines.Haicker's scalable architecture ensures enhanced performance as computational resources and AI models evolve and become more cost-effective. By leveraging a distributed approach where multiple AI agents concurrently analyze the same piece of code, Haicker ensures comprehensive vulnerability detection with unprecedented depth and efficiency.Targeted at security-conscious enterprises, software development teams, and DevSecOps practitioners, Haicker empowers organizations to shift security left, integrating deep vulnerability detection early into the development lifecycle. Its intuitive interface and streamlined integration capabilities with leading code management platforms such as GitHub, GitLab, and Bitbucket enable effortless adoption.Founded in Switzerland by cybersecurity and web development experts, Haicker is positioned to transform the application security market by offering a smarter, faster, and more reliable alternative to manual penetration tests and legacy automated scanning solutions.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
- Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
Private Investment Company
Show more...Investment focus
- Industry: Manufacturing, Software, Apps
- Stage:Seed, Series A
- Geography: Switzerland, Spain, Sweden
Investor stats
- Total investments: 26
- Round size: Seed $350k–$3.4M; Series A $2.1M–$3.5M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- CompPair — CompPair develops sustainable composites with an ultra-fast repair technology to extend their lifetime and reduce waste.
- Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
- Fidentity — Certified identification and signing solutions from fidentity. For better conversion rates. Maximum reliability and quick time-to-market.
Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team
Show more...Investment focus
- Industry: Health Care, Hardware, Software
- Stage:Seed, Series A
- Geography: Switzerland, France
Investor stats
- Total investments: 13
- Round size: Seed $1.2M–$5.3M; Series A $4.1M–$7M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Wyth — Wyth creates private digital spaces for virtual and hybrid audiences. With our fully customizable platform organizations can build a seamless experience and an online home for their communities to connect, learn, work, share and play without ever leaving Wyth. We give our customers full control over their brand experience, data ownership andbusiness relationships.
- Xsensio — Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
- Avelo — Our mission is to save lives by bringing fast and actionable infectious disease diagnosis closer to the patient. Avelo's solution is a breath collection device. It works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia
Momenta is the leading Industrial Impact® venture capital firm, accelerating industrial innovators across energy, manufacturing, smart spaces, and the supply chain. For over a decade, our team of deep industry operators has helped scale industry leaders and innovators to improve critical industries, the environment, and people's quality oflife. PitchBook has ranked Momenta as one of the ten best-performing venture capital firms for 2023 in its prestigious Global Manager Performance Score League Tables, and the firm is the only European-headquartered VC to secure a Top 10 spot on the list.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet of Things
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 84
- Round size: Seed $1M–$5.3M; Series A $2.9M–$23M; Series B $21M–$60M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Agtonomy — Smart Automation Made Simple
- Composabl — Composabl is a platform for creating industrial-strength, skill-based agents that work in real life. Composabl agents can control manufacturing equipment or make decisions for manufacturing and logistics processes.
- Overview.ai — Deploy deep learning vision inspection in days. Train models in hours with 10x fewer images. Edge-computing cameras achieve 99.9%+ accuracy on micron-level defects.
4FO Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland
Investor stats
- Total investments: 15
- Round size: Seed $2.1M–$3.6M; Series A $2.1M–$15M; Series B $6.4M–$54M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
- ARTIRIA Medical — Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
We help smart startups to establish and enhance their products and services. We also assist our holdings with their strategic planning activities and offer them shared services and networking platforms. Our collaboration with these entrepreneurs is focused on the pursuit of long-term goals.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $1.3M–$5.5M; Series A $2.3M–$8.2M; Series B $6.4M–$34M
- Lead/follow: 78% lead, 22% follow
- Last fund: Likely still investing — raised $128M in 2022
Portfolio highlights
- Lyfegen — Lyfegen is the first of its kind, a company making value-based healthcare contracting for high-cost therapies a reality for all healthcare stakeholders.
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- Particula — At Particula, we're at the forefront of the digital asset ecosystem. We've launched the first rating and data platform for tokenized real-world assets, focusing on alternative investments.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Investor funding in Switzerland at a glance
Stats across 4.5k deals from 3.6k investors.
Access all 3603 investors in Switzerland startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 3603 investors investing in Switzerland startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!